How many clinical trials are studying Psilocybin (drug)?

5 recruiting trials in our tracked data involve Psilocybin (drug).

What conditions is Psilocybin (drug) being studied for?

In our tracked recruiting trials, Psilocybin (drug) is being studied in trials for Depression, Alzheimer's disease, Anhedonia in Healthy Volunteers.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 1 2 Phase 2 4

Condition	Trials
Depression · Psilocybin (drug) for Depression	3
Alzheimer's disease	1
Anhedonia in Healthy Volunteers	1
Anxiety	1
Generalized Anxiety Disorder (GAD)	1
Major Depressive Diorder	1
Older Adults (50-90 Years)	1
Parkinson's Disease (PD)	1
Parkinson's disease	1
Treatment Resistant Depression	1

A Study of Psychedelics in Healthy Older Adults With Low Well-being
NCT07386730 · Phase: Phase 1 · Ages: 50 Years to 85 Years · Sex: All (male and female) · 1 location
Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression
NCT07183748 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
RCT of Psilocybin-assisted CBT for Depression
NCT07281352 · Phase: Phase 1, Phase 2 · Ages: 21 Years to 60 Years · Sex: All (male and female) · 1 location
Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder
NCT06969170 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
NCT07610369 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location